| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Eric R Prossnitz | Q37378751 |
| Matthias Barton | Q55232606 | ||
| Matthias R Meyer | Q57367122 | ||
| P2093 | author name string | Elvira Haas | |
| P2860 | cites work | Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species | Q79997231 |
| Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries | Q80242286 | ||
| Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? | Q80624716 | ||
| Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway | Q80651323 | ||
| Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway | Q83117517 | ||
| A transmembrane intracellular estrogen receptor mediates rapid cell signaling | Q24294726 | ||
| Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells | Q24314404 | ||
| Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha | Q24317626 | ||
| Integration of the extranuclear and nuclear actions of estrogen | Q24533536 | ||
| A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22) | Q24681542 | ||
| Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR | Q24681766 | ||
| Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA) | Q24805380 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women | Q28251695 | ||
| Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
| Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF | Q29615227 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase | Q29617567 | ||
| The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane | Q30432909 | ||
| Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase | Q30439814 | ||
| Estrogen prevents bovine aortic endothelial cells from TNF-alpha-induced apoptosis via opposing effects on p38 and p44/42 CCDPK. | Q33183532 | ||
| Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol | Q33564705 | ||
| Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression | Q79330536 | ||
| The protective effects of estrogen on the cardiovascular system | Q33654314 | ||
| Apoptosis in atherosclerosis: beneficial or detrimental? | Q33870047 | ||
| Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity | Q33898099 | ||
| Estrogen receptors: selective ligands, partners, and distinctive pharmacology | Q34063578 | ||
| Mechanisms of estrogen action | Q34093297 | ||
| Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis | Q34107645 | ||
| Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection? | Q34232000 | ||
| 17beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression | Q34283620 | ||
| The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. | Q34314290 | ||
| Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells | Q34573717 | ||
| Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice | Q34849712 | ||
| Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells | Q34960728 | ||
| Rapid vascular cell responses to estrogen and membrane receptors | Q34964032 | ||
| Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase | Q35676197 | ||
| Estrogen signaling: a subtle balance between ER alpha and ER beta | Q35679583 | ||
| Genomic targets of nuclear estrogen receptors | Q35697315 | ||
| Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription | Q35723711 | ||
| Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling | Q35754878 | ||
| Genomic and non-genomic effects of estrogens on endothelial cells | Q35853382 | ||
| Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes | Q36032594 | ||
| Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation | Q36082245 | ||
| Molecular and cellular basis of cardiovascular gender differences | Q36157696 | ||
| Endothelium-derived hyperpolarizing factor: where are we now? | Q36423629 | ||
| Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling | Q36465201 | ||
| GPR30 contributes to estrogen-induced thymic atrophy | Q36487627 | ||
| Minireview: estrogen receptor-mediated rapid signaling | Q36583156 | ||
| Transmitting on actin: synaptic control of dendritic architecture | Q36704180 | ||
| Receptor mechanisms mediating non-genomic actions of sex steroids | Q36796986 | ||
| Non-genomic sex steroid actions in the vascular system. | Q36796998 | ||
| Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors | Q36905110 | ||
| Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton | Q36931220 | ||
| Signaling by estrogens | Q36948478 | ||
| MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways | Q37080335 | ||
| Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. | Q37083658 | ||
| Vascular actions of estrogens: functional implications | Q37088243 | ||
| Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton | Q37097485 | ||
| Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis | Q37131823 | ||
| Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity | Q37435268 | ||
| 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30. | Q39943974 | ||
| Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. | Q40102215 | ||
| Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. | Q40155405 | ||
| G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells | Q40169554 | ||
| 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. | Q40256550 | ||
| Estrogen and raloxifene induce apoptosis by activating p38 mitogen-activated protein kinase cascade in synthetic vascular smooth muscle cells | Q40635700 | ||
| Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase | Q40679246 | ||
| Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen | Q40690125 | ||
| Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells | Q40849536 | ||
| Growth factors and mitogen-activated protein kinases | Q41695587 | ||
| Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane | Q41715384 | ||
| Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase | Q42436923 | ||
| Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. | Q42511593 | ||
| ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions | Q43843581 | ||
| Endothelium and atherogenesis: endothelial therapy revisited. | Q43866347 | ||
| ERbeta has nongenomic action in caveolae | Q43974252 | ||
| Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells | Q44033734 | ||
| Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: role of p38 and p42/44 mitogen-activated protein kinase | Q44177913 | ||
| Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation | Q44534247 | ||
| Membrane Estrogen Receptor-Dependent Extracellular Signal-Regulated Kinase Pathway Mediates Acute Activation of Endothelial Nitric Oxide Synthase by Estrogen in Uterine Artery Endothelial Cells | Q44598338 | ||
| Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism | Q44614402 | ||
| Role of putative membrane receptors in the effects of estradiol on human vascular cell growth | Q44864402 | ||
| Plasma membrane estrogen receptors exist and functions as dimers | Q44962115 | ||
| Estrogen and progesterone inhibit vascular smooth muscle proliferation. | Q45960627 | ||
| A conserved mechanism for steroid receptor translocation to the plasma membrane | Q46081038 | ||
| Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities | Q46515238 | ||
| Genomic deletion of estrogen receptors ERalpha and ERbeta does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes | Q46623199 | ||
| The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells | Q46765825 | ||
| Estrogen signals to the preservation of endothelial cell form and function | Q46880176 | ||
| Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells | Q46944972 | ||
| Nature of functional estrogen receptors at the plasma membrane. | Q50732202 | ||
| Direct interactions with G α i and G βγ mediate nongenomic signaling by estrogen receptor α . | Q52578149 | ||
| Src is an initial target of sex steroid hormone action | Q58213264 | ||
| GPR30: a novel indicator of poor survival for endometrial carcinoma | Q61772052 | ||
| Inhibition of estrogen-induced cyclic AMP elevation in rat uterus. II: By glucocorticoids | Q68601704 | ||
| Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro | Q72722193 | ||
| A study of the mechanism of estrogen as an antiatherosclerotic: The inhibitory effect of estrogen on A23187-induced contraction of the aortic wall | Q72923912 | ||
| Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae | Q73221516 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell function | Q95674809 |
| P304 | page(s) | 9-16 | |
| P577 | publication date | 2009-03-25 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | Non-genomic regulation of vascular cell function and growth by estrogen | |
| P478 | volume | 308 |
| Q34502756 | 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity |
| Q36800401 | Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER |
| Q36302657 | Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA. |
| Q29347039 | Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats |
| Q37030029 | Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation. |
| Q49887672 | Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia |
| Q35919356 | Diethylstilbestrol affects the expression of GPER in the gubernaculum testis. |
| Q47249117 | Diethylstilbestrol regulates mouse gubernaculum testis cell proliferation via PLC-Ca2+ -CREB pathway. |
| Q91973285 | Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo? |
| Q35976612 | ER Alpha Rapid Signaling Is Required for Estrogen Induced Proliferation and Migration of Vascular Endothelial Cells |
| Q93333125 | Effects of Estrogens on Central Nervous System Neurotransmission: Implications for Sex Differences in Mental Disorders |
| Q34793993 | Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice |
| Q34116034 | Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase |
| Q89957911 | Estrogen and Bisphenol A in Hypertension |
| Q28307726 | Estrogen biology: new insights into GPER function and clinical opportunities |
| Q36578738 | Estrogen receptor ERα plays a major role in ethanol-evoked myocardial oxidative stress and dysfunction in conscious female rats |
| Q41877892 | Estrogen signaling through estrogen receptor beta and G-protein-coupled estrogen receptor 1 in human cerebral vascular endothelial cells: implications for cerebral aneurysms |
| Q91894759 | Estrogen stimulates SREBP2 expression in hepatic cell lines via an estrogen response element in the SREBP2 promoter |
| Q43006955 | Estrogenic pyrethroid pesticides regulate expression of estrogen receptor transcripts in mouse Sertoli cells differently from 17beta-estradiol |
| Q30090708 | Estrogens in Male Physiology |
| Q52586242 | Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD). |
| Q34052527 | Expression of the oestrogen receptor GPER by testicular peritubular cells is linked to sexual maturation and male fertility |
| Q60920158 | G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy |
| Q30425896 | G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis |
| Q34946257 | GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts |
| Q33835934 | GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure. |
| Q61772039 | GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone |
| Q36797684 | General molecular biology and architecture of nuclear receptors |
| Q36788765 | Genetic control of estrogen-regulated transcriptional and cellular responses in mouse uterus |
| Q51271340 | Increased PELP1 expression in rat periodontal ligament tissue in response to estrogens treatment. |
| Q30408861 | Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males |
| Q38826180 | Methyltransferase-like 17 physically and functionally interacts with estrogen receptors |
| Q35032546 | Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. |
| Q34132206 | Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β |
| Q36191733 | Oestrogen receptor alpha in pulmonary hypertension |
| Q37191242 | Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. |
| Q33977389 | Research resource: Aorta- and liver-specific ERα-binding patterns and gene regulation by estrogen |
| Q38280772 | Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases |
| Q50989642 | Role of GPER in estrogen-dependent nitric oxide formation and vasodilation. |
| Q37795806 | Sex-Based Differences in Vascular Function |
| Q37339848 | Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. |
| Q35022398 | Temporal expression of Pelp1 during proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells |
| Q43171849 | Testosterone and secondary hypertension: new pieces to the puzzle. |
| Q36886122 | Testosterone-derived estradiol production by male endothelium is robust and dependent on p450 aromatase via estrogen receptor alpha. |
| Q35551803 | The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function |
| Q27013052 | The G-protein-coupled estrogen receptor GPER in health and disease |
| Q38727579 | The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview. |
| Q36439650 | The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells |
| Q36017502 | The role of estrogen on the pathology of cerebral aneurysms |
| Q42467900 | The soyabean isoflavone genistein modulates endothelial cell behaviour |
| Q39203266 | Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives. |
Search more.